Navigation Links
VisEn Launches New Cat B 680 FAST(TM) Fluorescence Molecular Imaging Agent
Date:1/20/2010

and 680 FAST™.  VisEn also offers specialized lines of in vivo agent labeling platforms, including its proprietary VivoTag® fluorescence labeling dyes for custom agent development and its NanoSpark® labeling nanoparticles.  They are all designed and optimized specifically for superior biocompatibility, brightness, stability and performance in in vivo imaging.  

All VisEn agents and labels are designed for in vivo biomarker quantification using VisEn's Fluorescence Molecular Tomography (FMT) imaging systems, or for general use along with other non-quantitative fluorescence in vivo imaging systems.  VisEn agents are also designed to enable complementary in vitro biomarker readouts in cells and tissues using standard fluorescence microscopy and cellular-based imaging systems.  With a focus on translational research and results, all of VisEn's technologies are designed to generate translational data linking pre-clinical research into clinical medicine.

About VisEn Medical Inc.

VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomography (FMT) Imaging Systems, provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo.  VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies worldwide in applications including oncology, arthritis, cardiovascular disease, skeletal disorders, and pulmonary disease. The Company also works with large pharmaceutical and clinical partners to design ranges of tailored molecular imaging agents and applications designed for their specific pre-clinical and clinical research areas.

Additional information can be found at '/>"/>

SOURCE VisEn Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
2. VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
3. VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
4. VisEn Launches New OsteoSense(R) 800 and VivoTag(R) 800 Fluorescence Molecular Imaging Agents
5. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
6. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
7. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
8. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
9. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
10. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
11. Premier Micronutrient Launches Supplement for Hearing Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... - The issue: In consultation ... lot (lot 710535) of Clavulin-400 (70mL) after receiving a complaint ... in one bottle of the  product. No other lots of ... Clavulin-400 is an oral antibiotic used in adults and children ... Clavulin-400 comes as a powder in bottles and is mixed ...
(Date:4/17/2015)... N.C. , April 17, 2015 ... the Integrated Embolic Protection™ filter platform for angioplasty ... of a $5.6 million Series B financing round ... venture firm with a focus on medical devices, ... The round also included Mountain Group Partners, Lookout ...
(Date:4/17/2015)... , April 17, 2015  Regulatory leaders in the ... bipartisan discussion draft called "21 st Century Cures." ... to be taken up by Congress soon and if ... medical device products are developed and marketed in ... many companies have begun to consider how the proposed ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... able to save part of each kidney in ... tumors appear on preoperative,scans, MEMPHIS, Tenn., March ... demonstrated that children with bilateral,Wilms tumor, a cancer ... both,kidneys by undergoing a procedure called bilateral nephron-sparing ...
... Pre-existing Lamivudine Resistance Predisposes Patients to ... Higher Rates of BARACLUDE Resistance ... data presented today demonstrated a continued low incidence of,resistance ... nucleoside-naive chronic hepatitis B patients analyzed, no additional,patient developed ...
Cached Medicine Technology:St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 3BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 5BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 6
(Date:4/19/2015)... Houston, Texas (PRWEB) April 19, 2015 ... is pleased to announce the publication of white paper ... Online Affair . As online media provides a ... whole new niche market specifically targeting adulterous spouses ... which an affair becomes as easy as shopping online. ...
(Date:4/18/2015)... April 19, 2015 The Residential ... during the past five years. The industry, which provides ... unable to fully care for themselves, has boomed on ... for dementia care for seniors with memory impairment. As ... an annualized rate of 4.1% to $1.9 billion over ...
(Date:4/18/2015)... PA (PRWEB) April 18, 2015 "I ... evacuation stretchers in healthcare facilities," said an inventor from ... alternative storage system." , He developed the Slyde Door ... doors used in healthcare facilities. It provides convenient storage ... there are more stretchers available for patients. , ...
(Date:4/18/2015)... 2015 Lower-auto-insurance.com has released a new ... auto insurance quotes . , Drivers can find ... quotes. A professional insurance brokerage website can help drivers ... a simple, convenient way. The whole process is designed ... , Comparing online car insurance quotes is advantageous because ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released ... they say, “exposes a tactical shift by cyberattackers.” With everything ... introduced in 2014 - almost a million a day - ... be identified and patched by prominent manufacturers – as long ... business in a digital world can be fraught with peril, ...
Breaking Medicine News(10 mins):Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
... prevention office of the Ministry of Health released a data ... which//, around 45,000 new cases of eyesight loss are reported ... reported 12 million people handicapped with eye problems, including about ... director with the blindness prevention office in East China's Shandong ...
... sickness or Human African trypanosomiasis is caused by the bite ... passes on the parasite called the trypanosome, to human beings ... disease over the past two decades in Sub-Saharan Africa. The ... of the number of people suffering this sickness, which is ...
... for protection of traditional medicines that they say is ... practitioners. ,Mei Zhinan, an expert in traditional ... said 80 percent of China's 55 minority groups, accounting ... billion population, had their own traditional medicines and secret ...
... accredited NewYork-Presbyterian Hospital as a Bariatric Surgery Center Network ... recognition of the Hospital's ability to offer patients the ... for New York state and one of only seven ... 20 years of age and older are obese -- ...
... by S. Kankova and colleagues from the Departments of ... Reproductive Medicine; and GynCentrum, in the Czech Republic, women ... than women who are Toxoplasma negative. // ... in human with a universal occurrence of 20-80%. This ...
... role in longevity, with longer-lived rodents showing significantly lower ... new study has found.// ,The study further strengthens ... shorter its life, and vice versa, said Mario Pinto, ... regulate metabolic rate. ,“Thyroid hormones are key ...
Cached Medicine News:Health News:Understanding Sleeping Sickness 2Health News:Understanding Sleeping Sickness 3Health News:Chinese Experts Call for Protection of Traditional Medicines 2Health News:NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery 2Health News:Effect of parasitic infection on baby's sex 2Health News:Longer-Lived Rodents Have Lower Levels of Thyroid Hormone 2
... The VASER System represents a ... ultrasonic technology to cosmetic procedures. Combined ... selective tissue emulsification, a solid grooved ... the VASER System has been designed ...
... The next generation of the ... PSI-TEC III retains all the ... PSI-TEC a leading name for,aspiration ... flow,vacuum pumps for high powered ...
Richardson Retractor...
Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
Medicine Products: